Jul 30
|
Nascent Biotech Presents at the July Emerging Growth Conference
|
Feb 6
|
Nascent Biotech and Manhattan BioSolutions Collaborate to Explore Pritumumab Antibody-Drug Conjugates
|
Jan 9
|
Nascent Biotech Receives an Analyst Opinion Suggesting that of the Company is Significantly Under Valued
|
Dec 19
|
Nascent Biotech Completes Payment of Variable Convertible Note in Full to Eliminate Dilution Risk
|
Nov 29
|
Nascent Biotech Granted Japanese Patent for Crossing Blood-Brain Barrier
|